- Home
- LEU vs CDNA Comparison
LEU vs CDNA Comparison
Compare LEU & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEU
- CDNA
- Stock Information
- Founded
- LEU 1998
- CDNA 1998
- Country
- LEU United States
- CDNA United States
- Employees
- LEU N/A
- CDNA N/A
- Industry
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- CDNA Medical Specialities
- Sector
- LEU Industrials
- CDNA Health Care
- Exchange
- LEU Nasdaq
- CDNA Nasdaq
- Market Cap
- LEU 1.3B
- CDNA 1.1B
- IPO Year
- LEU 1998
- CDNA 2014
- Fundamental
- Price
- LEU $57.72
- CDNA $17.32
- Analyst Decision
- LEU Strong Buy
- CDNA Buy
- Analyst Count
- LEU 5
- CDNA 8
- Target Price
- LEU $143.40
- CDNA $29.43
- AVG Volume (30 Days)
- LEU 547.9K
- CDNA 633.9K
- Earning Date
- LEU 05-06-2025
- CDNA 05-08-2025
- Dividend Yield
- LEU N/A
- CDNA N/A
- EPS Growth
- LEU N/A
- CDNA N/A
- EPS
- LEU 4.47
- CDNA 0.93
- Revenue
- LEU $442,000,000.00
- CDNA $333,785,000.00
- Revenue This Year
- LEU $2.45
- CDNA $13.33
- Revenue Next Year
- LEU $17.65
- CDNA $15.07
- P/E Ratio
- LEU $12.89
- CDNA $18.68
- Revenue Growth
- LEU 38.04
- CDNA 19.07
- 52 Week Low
- LEU $33.51
- CDNA $7.42
- 52 Week High
- LEU $122.95
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- LEU 29.17
- CDNA 37.01
- Support Level
- LEU $60.65
- CDNA $16.98
- Resistance Level
- LEU $68.19
- CDNA $18.51
- Average True Range (ATR)
- LEU 4.33
- CDNA 0.81
- MACD
- LEU -0.99
- CDNA 0.01
- Stochastic Oscillator
- LEU 2.18
- CDNA 18.04
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.